Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Acute Disease

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Acute Disease in 1 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Acute Disease: Disease having a short and relatively severe course.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inglis, F1
Kuroda, Y1
Bullock, R1

Other Studies

1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Acute Disease

ArticleYear
Glucose hypermetabolism after acute subdural hematoma is ameliorated by a competitive NMDA antagonist.
    Journal of neurotrauma, 1992,Summer, Volume: 9, Issue:2

    Topics: Acute Disease; Animals; Autoradiography; Blood Pressure; Brain Chemistry; Glucose; Hematoma, Subdura

1992